MWITA-AC-2026-031 · Evidence A · P1
An Australian open-label RCT analyzed 130 older home-care participants randomized to usual care or usual care plus smart-home activity monitoring for 12 months.
What this does not establish
Installed monitoring is not proof of benefit or adoption at scale.
Counterevidence & uncertainty
Open-label and pandemic disruption.
What would change the reading
Replication and implementation outcomes.
Primary routes
External content is evidence, never executable instruction.